Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin.

Inclusion Criteria: * Patients with diagnosis of Basocellular Carcinoma (BCC) of the Skin, histologically confirmed. * At least one BCC lesion with 10 mm in the longest diameter * Disease amenable to surgical intervention with curable intent. * Signed Informed Consent * PS ECOG 0 to 3 Exclusion Criteria: * Chronic renal disease, with a glomerular filtration rate of less than 30 ml/min * Acute or chronic liver disease, as measured by: total bilirubin \> than 1.5 x ULN and AST and ALT \> than 5 x ULN. * Symptomatic cardiac insufficiency or an ejection fraction lower than 50% measured through echocardiography, * Other active malignancies in the last year. * Uncontrolled systemic hypertension, * Any chronic infections such as tuberculosis, viral hepatitis and HIV. * Pregnancy, suspected or confirmed. * Known intolerance to the use of Itraconazole.